Home  >> Transactions>> AHN biotechnologie has been sold to Capp

AHN biotechnologie has been sold to Capp

Harvard Bioscience, Inc. (Nasdaq: HBIO) has sold its subsidiary, AHN Biotechnologie GmbH, to Capp ApS. Based in Nordhausen, Germany, AHN Biotechnologie specializes in the development, manufacturing and distribution of liquid handling products for the use in laboratories worldwide.

Others

Halma's SunTech Medical acquires CASMED's blood pressure monitoring product line      Learn More >>
Rotronic AG is sold to Process Sensing Technologies      Learn More >>
Ratos divests Sophion Bioscience      Learn More >>
Parasense is sold to Bacharach      Learn More >>
Nova Instruments Acquires Stresstech Oy      Learn More >>
Spartaco acquires Tiiger      Learn More >>
Union Park Capital acquires Systech Illinois      Learn More >>
Xylem has sold PCI Membranes to Madison Industries      Learn More >>
In-Situ acquires MACE      Learn More >>
KSB has sold AMRI to Bray      Learn More >>
Nova Instruments Acquires Degree Controls Inc.      Learn More >>
Suez has sold Ameriwater to Empire IH      Learn More >>